Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in perceptions of hematologists and palliative care physicians regarding transfusion therapy in patients with terminal hematological malignancies: a nationwide cross-sectional questionnaire survey in Japan.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib era.

Scientific reports·2026
Same author

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.

Annals of hematology·2026
Same author

Living sensor display implanted on skin for long-term biomarker monitoring.

Nature communications·2026
Same author

Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia.

International journal of hematology·2025
Same author

Masao Washizu (1953-2025).

Nature biomedical engineering·2025

Related Experiment Video

Updated: Jun 22, 2026

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.

Naoto Tomita1, Kengo Takeuchi, Rie Hyo

  • 1Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. cavalier@ch-yamate.dlenet.com

Acta Haematologica
|May 27, 2009
PubMed
Summary

Immunoglobulin light chain restriction (LCR)-negative diffuse large B cell lymphoma (DLBCL) comprises 24% of cases and shares similar clinical features and prognosis with LCR-positive DLBCL. CD10-negative status may characterize LCR-negative DLBCL.

More Related Videos

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry
09:02

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry

Published on: October 14, 2021

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Related Experiment Videos

Last Updated: Jun 22, 2026

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry
09:02

Isolation of Uterine Innate Lymphoid Cells for Analysis by Flow Cytometry

Published on: October 14, 2021

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Immunoglobulin light chain restriction (LCR) is a key indicator of B cell monoclonality.
  • LCR-deficient B cell malignancies, particularly diffuse large B cell lymphoma (DLBCL), are frequently observed but poorly understood.

Purpose of the Study:

  • To investigate the clinical characteristics of LCR-negative DLBCL.
  • To compare LCR-negative DLBCL with LCR-positive DLBCL in terms of clinical features, immunophenotype, and prognosis.

Main Methods:

  • Retrospective analysis of 119 consecutive DLBCL patients.
  • Classification into LCR-positive (76%) and LCR-negative (24%) groups based on flow cytometry (FCM).
  • Comparison of clinical parameters (International Prognostic Index, B-symptoms, bulky mass), immunophenotype (CD10, CD5), and chromosomal translocations (BCL2, BCL6, MYC) between the groups.

Main Results:

  • No significant differences were observed in International Prognostic Index, gender, bulky mass, or B-symptoms between LCR-positive and LCR-negative DLBCL.
  • CD10-positive cases were less frequent in LCR-negative DLBCL, and CD5-positive cases were absent.
  • Frequencies of BCL2, BCL6, and MYC translocations did not differ between the groups, and survival outcomes were similar.

Conclusions:

  • LCR-negative DLBCL constitutes approximately 24% of all DLBCL cases.
  • LCR-negative DLBCL exhibits a similar prognosis to LCR-positive DLBCL.
  • CD10-negative status may serve as a potential characteristic marker for LCR-negative DLBCL.